TABLE 2.

Inhibitors targeting autophagy‐related factors.

Targeted ATG	Compound	IC50	Reference
ULK1/ULK2	SBI‐0206965	108 nM/711 nM	69
	MRT67307	45 nM/38 nM	70
	MRT68921	2.9 nM/1.1 nM
	Compound 6	8 nM/−	71
	ULK‐100	1.6 nM/2.6 nM	72
	ULK‐101	8.3 nM/30 nM
VPS34	SAR405	1.2 nM	73
	VPS34‐IN1	25 nM	74
	PIK‐III	18 nM	75
	Compound 31	2 nM	76
	SB02024	14 nM	77
ATG7	Compound 18	48 nM	78
	Compound 19	52 nM
	Compound 37	62 nM
Atg4A/Atg4B	NSC185058	−/50 μM	79
	Tioconazol	1.3 μM/1.8 μM	80
	LV320	35.5 μM/24.5 μM	81
	S130	7.11 μM/3.24 μM	82
	FMK‐9a	−/80 nM	83
	UAMC‐2526	−/−	84
ATG4B‐LC3 PPI	SUPR4B1W	120 nM (KD)	85
ATG5‐ATG16L1 PPI	Peptide 10	12 nM (KD)	86
Beclin1‐ATG14L PPI	Cmpound 19	33.9 uM	87

Note: (−): not applicable, not available.